We are here to help! If you can answer ‘yes’ to any of the following, we can provide educational information to your Urologist.
Are you:
Newly diagnosed with prostate cancer?
Currently on active surveillance?
If you are interested and would like us to reach out to your provider, please fill out their information below
You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy.
Contact Information
Gleason scoring plays a vital role in determining prostate cancer treatment decisions. Since the 1970s, Gleason has been used to assess the aggressiveness of a patient’s prostate cancer. Unfortunately, Gleason grading and scoring can be largely subjective, in fact, 34% of the time, expert-trained Pathologists disagree about biopsy Gleason scores1. This is where the Prolaris test comes in.
Prolaris is an advanced genetic test that combines tools like Gleason score and PSA with a personalized tumor score to determine how aggressive your prostate cancer is. Prolaris helps you decide which treatment option is best based on your cancer.
Prolaris is for any untreated man with prostate cancer and helps you answer your most pressing questions like:
65%
In two clinical utility studies, Prolaris results lead to change in management in up to 65% of patients.2,3,4
2x
The Prolaris score is 2x more prognostic than PSA and Gleason score combined5
$0
97% of patients pay $0 out of pocket
“Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”
Tim Petracca
Contact our trusted advisors for personalized support.
Learn how genetic testing can provide better answers for the best prostate cancer treatment for you in our FREE Patient Testing Guide.